Pulse Biosciences, Inc. PLSE Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$74.57M-23.8% | -$72.78M-35.8% | -$74.73M-62.0% | -$68.03M-54.5% | -$60.24M-41.6% | ||
| $381K-13.0% | $410K-9.5% | $438K-6.8% | $438K-6.8% | $438K-6.8% | ||
| $17.69M+1.0% | $21.46M+57.9% | $23.28M+130% | $20.65M+131% | $17.51M+118% | ||
| —— | —— | —— | —— | —— | ||
| $176K+487% | $136K— | $57K— | $51K— | $30K— | ||
| —— | —— | $1.31M— | —— | —— | ||
| —— | —— | —— | —— | $1.72M— | ||
| —— | —— | —— | $372K+264% | $32K-80.0% | ||
| —— | —— | —— | —— | —— | ||
| $666K+0.2% | $665K-0.2% | $665K-0.2% | $666K+0.2% | $665K0.0% | ||
| $1.19M— | $1.15M— | $1.1M— | $1.04M— | —— | ||
| -$1.42M-23.7% | -$1.37M-27.1% | -$1.31M-28.5% | -$1.23M-25.8% | -$1.15M-22.9% | ||
| -$55.2M-37.7% | -$54.12M-48.9% | -$48.51M-42.8% | -$44.5M-25.5% | -$40.08M-10.6% | ||
| $303K+83.6% | $315K+152% | $263K+129% | $239K+139% | $165K+89.7% | ||
| -$323K-95.8% | -$335K-168% | -$283K-146% | -$259K-159% | -$165K-89.7% | ||
| $3.78M+204% | $2.49M+186% | $2.47M+397% | $1.24M+5,541% | $1.24M+13,700% | ||
| $4.56M-96.4% | $17.15M-84.5% | $64.98M+3.1% | $124.91M+3,734% | $124.91M+629% | ||
| -$50.96M-160% | -$37.3M-151% | $16.18M-43.5% | $80.15M+346% | $84.39M— | ||
| $666K+0.2% | $665K-0.2% | $665K-0.2% | $666K+0.2% | $665K0.0% | ||
| $381K-13.0% | $410K-9.5% | $438K-6.8% | $438K-6.8% | $438K-6.8% | ||
| -$1.42M-23.7% | -$1.37M-27.1% | -$1.31M-28.5% | -$1.23M-25.8% | -$1.15M-22.9% | ||
| $760K— | $912K— | —— | —— | —— | ||
| $1.19M— | $1.15M— | $1.1M— | $1.04M— | —— | ||
| —— | —— | —— | —— | —— | ||
| $57K— | $0— | $59K— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| $167K-99.7% | $14.11M-71.4% | $61.98M— | $63.5M— | $63.5M— | ||
| —— | —— | —— | —— | —— | ||
| -$1.42M-23.7% | -$1.37M-27.1% | -$1.31M-28.5% | -$1.23M-25.8% | -$1.15M-22.9% | ||
| —— | $0-100% | $207.5K-66.7% | $415K0.0% | $622.5K+200% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | $20.75K— | ||
| —— | —— | —— | —— | —— | ||
| -$55.5M-37.9% | -$54.44M-49.3% | -$48.77M-43.0% | -$44.74M-25.9% | -$40.25M-10.8% | ||
| -$55.5M-37.9% | -$54.44M-49.3% | -$48.77M-43.0% | -$44.74M-25.9% | -$40.25M-10.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Pulse Biosciences, Inc. generate?
- Pulse Biosciences, Inc. (PLSE) generated -$55.2M in operating cash flow over the trailing twelve months.
- What is Pulse Biosciences, Inc.'s free cash flow?
- After $303.0K of capital expenditures, Pulse Biosciences, Inc.'s free cash flow was -$55.5M over the trailing twelve months, down 37.9% year over year.
- Where does Pulse Biosciences, Inc.'s cash flow data come from?
- Every line is extracted from Pulse Biosciences, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
